Burstable Editorial Team
NewsRamp Burstable Feed
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
21769 articles
Articles
Auddia Files S-4 for Merger with Thramann Holdings, Paving Way for McCarthy Finney AI Platform
Auddia Inc. filed a registration statement with the SEC for its merger with Thramann Holdings, which will create McCarthy Finney, a unified AI holding company operating four AI-enabled businesses on a shared platform.
May 15, 2026Read the full article
Daryl Judy Named KeyCrew Verified Expert in DC Luxury Real Estate
KeyCrew Media has selected Daryl Judy, Associate Broker at Washington Fine Properties, as a Verified Expert to provide exclusive market intelligence on luxury residential real estate across the DC region, highlighting his track record and off-market expertise.
May 15, 2026Read the full article
BioStem Technologies Reports First Quarter 2026 Financial Results Amid Strategic Transformation
BioStem Technologies reported Q1 2026 net revenue of $6.1 million, a decrease from prior quarters, as the company focuses on integrating acquired BioTissue assets and advancing toward a Nasdaq uplisting.
May 14, 2026Read the full article
GeoVax Reports First Quarter 2026 Financial Results, Advances GEO-MVA Phase 3 Trial and Gedeptin Immuno-Oncology Program
GeoVax Labs reported a net loss of $5.3 million for Q1 2026, while advancing its GEO-MVA mpox/smallpox vaccine toward a Phase 3 trial under an EMA-aligned expedited pathway and strengthening its Gedeptin immuno-oncology platform with a new Emory University license.
May 14, 2026Read the full article
Aemetis Reports Strong First Quarter Results as 45Z Tax Credits Begin to Boost Earnings
Aemetis, Inc. reported a 27% year-over-year revenue increase to $54.6 million in the first quarter of 2026, with recurring 45Z tax credit recognition and improved renewable natural gas economics driving a positive shift in gross profit and adjusted EBITDA.
May 14, 2026Read the full article
HeartBeam Reports First-Quarter 2026 Results, Advances Commercial Launch with New Partnerships and $11.5M Public Offering
HeartBeam reported a narrower net loss of $4.7 million in Q1 2026, launched initial commercial partnerships, and raised $11.5 million to support its FDA-cleared 3D ECG platform for heart attack detection and ambulatory monitoring.
May 14, 2026Read the full article
BOXABL and FG Merger II Advance Toward Public Listing as SEC Declares S-4 Effective
BOXABL and FG Merger II Corp. have reached a key milestone in their proposed business combination, with the SEC declaring their Form S-4 effective, setting the stage for BOXABL to become a publicly traded company on Nasdaq under the ticker BXBL.
May 14, 2026Read the full article
Carmed Pharmaceuticals Expands U.S. Presence with Launch on OneLavi.com
Carmed Pharmaceuticals, a Turkey-based company, launches select carvacrol-based formulations on OneLavi.com, marking a key step in its U.S. expansion strategy through curated wellness platforms.
May 14, 2026Read the full article
Comedy Village to Bring Live Stand-Up Comedy to Ninth Avenue International Food Festival in Times Square and Hell's Kitchen
Comedy Village will host a live stand-up comedy showcase at the 51st Annual Ninth Avenue International Food Festival on May 17, 2026, featuring nationally recognized comedians and blending NYC's iconic food culture with its legendary comedy scene.
May 14, 2026Read the full article
Dogwood Therapeutics Reports First Quarter 2026 Financial Results and Pipeline Progress
Dogwood Therapeutics announced first quarter 2026 financial results, highlighting advancement of Halneuron® Phase 2b CINP study with top-line data expected fall 2026 and FDA clearance for SP16 to enter Phase 1b, with $13.2 million cash runway into Q4 2026.
May 14, 2026Read the full article
Cinderix Launches AI SEO Autopilot with 99% Automation, Targeting LLM Visibility
Cinderix releases AI SEO Autopilot, a system powered by OTTO agents that automates 99% of SEO tasks, including LLM visibility for AI search tools like ChatGPT and Gemini.
May 14, 2026Read the full article
Ontario Engineer Launches Consulting Practice to Build Custom Internal Tools for Fintech and SaaS Teams
Franz Wiebe, a product engineer from Aylmer, Ontario, has launched a consulting practice focused on developing custom internal tools and SaaS MVPs for fintech firms, ministry organizations, and early-stage software ventures, aiming to replace fragmented SaaS stacks with integrated systems that streamline operations.
May 14, 2026Read the full article
Keona Health Introduces Rule of ONE Framework to Standardize Healthcare Call Center Operations
Keona Health's analysis of fragmented healthcare call center workflows introduces the Rule of ONE framework, which aims to improve efficiency and consistency by centralizing and standardizing call handling processes.
May 14, 2026Read the full article
LIG Assets Advances SK-1300 Valuation for Marianna Calcium Mine
LIG Assets, Inc. is working on a SEC SK-1300 technical report to update the valuation of its calcium carbonate mining assets in Marianna, Florida, potentially reflecting significant increases from a prior $400 million estimate.
May 14, 2026Read the full article
HR.com Honors Harbinger Group and Willow Bridge Property Company with 2026 HR Tech Innovation & Implementation Awards
HR.com has announced the winners of its 2026 HR Tech Innovation & Implementation Awards, recognizing Harbinger Group for its AI-driven performance management tool and Willow Bridge Property Company for a large-scale HRIS modernization that unified five regional businesses.
May 14, 2026Read the full article
SureNano Science’s GLP-1 Triple Agonist Peptide GEP-44 Highlights Next-Generation Innovation in Metabolic Disease Treatment
SureNano Science Ltd., through its subsidiary GlucaPharm Inc., is advancing GEP-44, a novel triple agonist peptide with potential for enhanced efficacy and non-injectable delivery in the growing GLP-1 therapeutic market for obesity and type 2 diabetes.
May 14, 2026Read the full article
BluSky AI Launches Regulation A+ Offering for AI Infrastructure Expansion
BluSky AI Inc. has initiated a Regulation A+ offering to raise funds for expanding its distributed AI infrastructure network, allowing individual and accredited investors to participate with a minimum investment of $1,000.
May 14, 2026Read the full article
American Fusion Inc. Highlights Strategic Washington Engagements and Corporate Progress
American Fusion Inc. updates on D.C. meetings for defense and energy applications, Form 10 filing, and OTCQB pursuit, advancing its Texatron fusion platform toward commercialization.
May 14, 2026Read the full article
NextPlat Corp Reports Improved First-Quarter 2026 Results as Turnaround Initiatives Gain Traction
NextPlat Corp announced improved first-quarter 2026 operating results, including a record gross margin of 35% and a 42% reduction in net loss, driven by ongoing turnaround efforts despite lower year-over-year revenue.
May 14, 2026Read the full article
Aditxt Announces 1-for-27 Reverse Stock Split to Regain Nasdaq Compliance
Aditxt Inc. will implement a 1-for-27 reverse stock split effective May 18, 2026, to meet Nasdaq's minimum bid price requirement, reducing outstanding shares from approximately 13.8 million to about 510,123.
May 14, 2026Read the full article
Oncotelic Therapeutics Featured in BioMedWire Editorial Highlighting Nose-to-Brain Drug Delivery for Alzheimer's and Biodefense
Oncotelic Therapeutics' proprietary intranasal nose-to-brain delivery platform, featured in a BioMedWire editorial, offers a novel approach to bypass the blood-brain barrier for treating neurological diseases like Alzheimer's and advancing biodefense research.
May 14, 2026Read the full article